Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

228 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

NCT00546793

Conditions
CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
Locations
  • Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States
  • Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States
  • Morristown Memorial Hospital Morristown, New Jersey, United States
  • New York Hospital Weill Cornell Medical Center New York, United States
View Trial Details
Completed

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma

NCT01410630

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center - University of Texas Houston, Texas, United States
  • Aachen University Aachen, Germany
View Trial Details
Completed

Symbenda Post-Marketing Surveillance (PMS)

NCT02434484

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Eisai Trial Site #7 Busan, South Korea
  • Eisai Trial Site #8 Busan, South Korea
  • Eisai Trial Site #6 Daegu, South Korea
  • Eisai Trial Site #4 Daejeon, South Korea
View Trial Details
Completed

An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)

NCT03289182

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Soon Chun Hyang University Hospital Bucheon Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Keimyung University Dongsan Medical Center Daegu, South Korea
View all 25 locations
View Trial Details
Completed

Study of Lymphoma in Asia

NCT01584141

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations
  • Tianjin Medical University Cancer Institute & Hospital Hexi District, China
  • West China Hospital of Sichuan University Sichuan, China
  • Queen Mary Hospital Sai Ying Pun, Hong Kong
  • Buddhis Dalin Tzu Chi General Hospital Dalin Town, Taiwan
View Trial Details
Completed

Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma

NCT02581878

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Skanes Universitetssjukhus Lund, Sweden
  • Southampton General Hospital Southampton, Hampshire, United Kingdom
  • Royal Marsden NHS Trust (Surrey) Sutton, Surrey, United Kingdom
  • Royal Free Hospital London, United Kingdom
View Trial Details

Related conditions